Stockreport

Investors in Amicus Therapeutics (NASDAQ:FOLD) from a year ago are still down 19%, even after 3.9% gain this past week [Yahoo! Finance]

Amicus Therapeutics, Inc.  (FOLD) 
Last amicus therapeutics, inc. earnings: 11/11 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.amicusrx.com/investor-relations
PDF Investors in Amicus Therapeutics, Inc. NASDAQ:FOLD ) have tasted that bitter downside in the last year, as the share price dropped 19%. That contrasts poorly with the ma [Read more]